ARAY - Accuray Incorporated
| Previous close | 2.0200 |
| Open | 2.0400 |
| Bid | 1.9900 x 800 |
| Ask | 2.0000 x 800 |
| Day's range | 1.9600 - 2.0556 |
| 52-week range | 1.3300 - 4.6800 |
| Volume | 424,880 |
| Avg. volume | 621,551 |
| Market cap | 180.581M |
| Beta (5Y monthly) | 2.03 |
| PE ratio (TTM) | 90.68 |
| EPS (TTM) | 0.0220 |
| Earnings date | 13 Aug 2020 - 17 Aug 2020 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 7.00 |
- Simply Wall St.
Based On Its ROE, Is Accuray Incorporated (NASDAQ:ARAY) A High Quality Stock?
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
- Zacks
Coronavirus Spurs Growth for 3 Robotics-Assisted Surgery Stocks
In the face of the pandemic, the robotics-assisted surgery space continues to thrive on a slew of positive developments.
- Zacks
Accuray's New CyberKnife S7 System to Boost Patient Care
Accuray's (ARAY) newly launched CyberKnife S7 System will enable clinicians to provide best possible care to their patients through new capabilities.
- Zacks
Here's Why You Should Add Accuray to Your Portfolio Now
Investor confidence is high on Accuray (ARAY) stock, thanks to solid prospects.
- Zacks
Why Is Accuray (ARAY) Down 9.2% Since Last Earnings Report?
Accuray (ARAY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Zacks
Delivery Robots Making an Impression Amid Coronavirus Pandemic
Since the coronavirus outbreak, robots have filled up several job vacancies caused by social distancing orders. Here are five robotics and related stocks investors should closely watch.
- Zacks
How Accuray (ARAY) Stock Stands Out in a Strong Industry
Accuray (ARAY) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
- Simply Wall St.
Does Accuray Incorporated's (NASDAQ:ARAY) CEO Pay Compare Well With Peers?
Joshua Levine has been the CEO of Accuray Incorporated (NASDAQ:ARAY) since 2012. This report will, first, examine the...
- Simply Wall St.
Accuray Incorporated Just Reported A Surprise Profit And Analysts Updated Their Estimates
Shareholders will be ecstatic, with their stake up 24% over the past week following Accuray Incorporated's...
- Zacks
Will Accuray (ARAY) Gain on Rising Earnings Estimates?
Accuray (ARAY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
- Zacks
What Makes Accuray (ARAY) a New Strong Buy Stock
Accuray (ARAY) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- Motley Fool
Accuray Inc (ARAY) Q3 2020 Earnings Call Transcript
Welcome to Accuray's conference call to review financial results for the third quarter of fiscal year 2020, which ended March 31, 2020. Joining us today are Josh Levine, Accuray's President and Chief Executive Officer; and Shig Hamamatsu, Accuray's Senior Vice President and Chief Financial Officer.
- Simply Wall St.
When Can We Expect A Profit From Accuray Incorporated (NASDAQ:ARAY)?
Accuray Incorporated's (NASDAQ:ARAY): Accuray Incorporated designs, develops, and sells radiosurgery and radiation...
- Zacks
Change Healthcare (CHNG) Q3 Earnings Top Estimates, Down Y/Y
Change Healthcare's (CHNG) third-quarter fiscal earnings benefit from solid performance across the segments - Software and Analytics and Network Solutions. However, decline in revenues remains a woe.
- Zacks
DexCom (DXCM) Q4 Earnings and Revenues Surpass Estimates
DexCom's (DXCM) fourth-quarter earnings benefit from higher revenues and solid performing Sensor and Transmitter segments.
- Zacks
Bio-Rad (BIO) Q4 Earnings & Revenues Fall Short of Estimates
Bio-Rad's (BIO) fourth-quarter 2019 results reflect strong segmental performances.
- Zacks
AMN Healthcare (AMN) Q4 Earnings and Revenues Top Estimates
AMN Healthcare's (AMN) Q4 results gain from core Nurse and Allied Solutions units.
- Zacks
LabCorp's (LH) Q4 Earnings Beat Estimates, Margins Rise
LabCorp (LH) registered year-over-year growth in operating segments in Q4.
- Zacks
The Zacks Analyst Blog Highlights: Accuray, MagnaChip Semiconductor, Rite Aid, Vericel and RGC Resources
The Zacks Analyst Blog Highlights: Accuray, MagnaChip Semiconductor, Rite Aid, Vericel and RGC Resources
- Zacks
CVS Health (CVS) Q4 Earnings Top Estimates, Margins Improve
CVS Health (CVS) registers strong growth in Pharmacy Services, benefiting from the upside in specialty services.
- Zacks
Exact Sciences (EXAS) Q4 Earnings and Revenues Rise Y/Y
Exact Sciences' (EXAS) fourth-quarter 2019 results reflect strong segmental performances.
- Zacks
Virus or No Virus, Investing Case in US Stocks Looks Solid!
U.S. stocks are heavily exposed to the domestic economy where data continues to improve. And even if skeptics worry about the virus outbreak, developed markets are more stable than emerging markets during chaotic times.
- Zacks
Luminex (LMNX) Earnings and Revenues Beat Estimates in Q4
Luminex's (LMNX) fourth-quarter earnings benefit from higher revenues and solid performance across System Sales, Service and Other Revenues. However, gross margin contraction remains a woe.
- Zacks
DaVita (DVA) Earnings Beat Estimates in Q4, Revenues Miss
DaVita (DVA) gains from dialysis services in the United States in Q4.
- Zacks
STERIS (STE) Surpasses Q3 Earnings Estimates, Ups FY20 View
STERIS' (STE) third-quarter fiscal 2020 results reflect strong segmental performances.
